Avicenna Journal of Clinical Microbiology and Infection

Published by: Kowsar

Increasing Trend of Imipenem-Resistance Among Acinetobacter baumannii Isolated From Hospital Acquired Pneumonia in Northeast of Iran

Authors Information
1 Antimicrobial Resistance Research Center, Avicenna Research Institute, Department of Microbiology and Virology, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, IR Iran
2 Nursing Department Basic Sciences Faculty, Hamedan Branch, Islamic Azad University, Hamedan, IR Iran
3 Department of Microbiology, Faculty of Medicine, Hamadan University of Medical Sciences, Hamadan, IR Iran
4 Department of Modern Sciences and Technologies, School of Medicine, Mashhad University of Medical Sciences, Mashhad, IR Iran
5 Applied Microbiology Research Ccenter, and Microbiology Department, Baqiyatallah University of Medical Sciences, Tehran, IR Iran
Article Notes and Dates
Avicenna Journal of Clinical Microbiology and Infection: August 2017, 4 (3); e45454.Published Online: May 9, 2017
Article Type: Research Article; Received : January 12, 2017; Accepted : February 14, 2017
DOI: http://dx.doi.org/10.5812/ajcmi.45454

To Cite : Khaledi A, Elahifar O, Vazini H, Alikhani M Y, Bahrami A, et al. Increasing Trend of Imipenem-Resistance Among Acinetobacter baumannii Isolated From Hospital Acquired Pneumonia in Northeast of Iran, Avicenna J Clin Microb Infec. 2017 ;4(3):e45454. doi: 10.5812/ajcmi.45454.

Copyright: Copyright © 2017, Avicenna Journal of Clinical Microbiology and Infection. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
1. Background
2. Objectives
3. Methods
4. Results
5. Discussion
  • 1. Hollenbeak CS, Murphy D, Dunagan WC, Fraser VJ. Nonrandom selection and the attributable cost of surgical-site infections. Infect Control Hosp Epidemiol. 2002; 23(4): 177-82[DOI][PubMed]
  • 2. Shaikh JM, Devrajani BR, Shah SZ, Akhund T, Bibi I. Frequency, pattern and etiology of nosocomial infection in intensive care unit: an experience at a tertiary care hospital. J Ayub Med Coll Abbottabad. 2008; 20(4): 37-40[PubMed]
  • 3. Weinstein RA. Nosocomial infection update. Emerg Infect Dis. 1998; 4(3): 416-20[DOI][PubMed]
  • 4. American Thoracic S, Infectious Diseases Society of A. Guidelines for the management of adults with hospital-acquired, ventilator-associated, and healthcare-associated pneumonia. Am J Respir Crit Care Med. 2005; 171(4): 388-416[DOI][PubMed]
  • 5. Klevens RM, Edwards JR, Richards CJ, Horan TC, Gaynes RP, Pollock DA, et al. Estimating health care-associated infections and deaths in U.S. hospitals, 2002. Public Health Rep. 2007; 122(2): 160-6[DOI][PubMed]
  • 6. Tablan OC, Anderson LJ, Besser R, Bridges C, Hajjeh R. Healthcare infection control practices advisory committee. 2003;
  • 7. Chastre J, Fagon JY. Ventilator-associated pneumonia. Am J Respir Crit Care Med. 2002; 165(7): 867-903[DOI][PubMed]
  • 8. Nateghian A, Irajian G, Faraji F. Community Versus Nosocomial Staphylococcus aureus Septicemia in Children Admitted to Aliasghar Children Hospital, Tehran, Iran. Iran J Pathol. 2011; 6(2): 79-85
  • 9. Hakyemez IN, Kucukbayrak A, Tas T, Yikilgan AB, Akkaya A, Yasayacak A, et al. Nosocomial Acinetobacter baumannii infections and changing Antibiotic Resistance. Pak J Med Sci. 2013; 29(5)[DOI]
  • 10. Bahador A, Taheri M, Pourakbari B, Hashemizadeh Z, Rostami H, Mansoori N, et al. Emergence of rifampicin, tigecycline, and colistin-resistant Acinetobacter baumannii in Iran; spreading of MDR strains of novel International Clone variants. Microb Drug Resist. 2013; 19(5): 397-406[DOI][PubMed]
  • 11. Bahador A, Raoofian R, Farshadzadeh Z, Beitollahi L, Khaledi A, Rahimi S, et al. The Prevalence of ISAba1 and ISAba4 in Acinetobacter baumannii Species of Different International Clone Lineages Among Patients With Burning in Tehran, Iran. Jundishapur J Microbiol. 2015; 8(6)[DOI]
  • 12. Khaledi A, Hashemi FB, Bahador A. In vitro evaluation of MFS efflux pumps among multidrug resistant Acinetobacter baumannii isolated from patients hospitalized in ICU. Der Pharma Chemica. 2016; 8(1): 104-10
  • 13. Khan MM, Celik Y. Cost of nosocomial infection in Turkey: an estimate based on the university hospital data. Health Serv Manage Res. 2001; 14(1): 49-54[DOI][PubMed]
  • 14. Falagas ME, Bliziotis IA, Siempos ,I. Attributable mortality of Acinetobacter baumannii infections in critically ill patients: a systematic review of matched cohort and case-control studies. Crit Care. 2006; 10(2)[DOI][PubMed]
  • 15. Mendes RE, Farrell DJ, Sader HS, Jones RN. Comprehensive assessment of tigecycline activity tested against a worldwide collection of Acinetobacter spp. (2005-2009). Diagn Microbiol Infect Dis. 2010; 68(3): 307-11[DOI][PubMed]
  • 16. Quale J, Bratu S, Landman D, Heddurshetti R. Molecular epidemiology and mechanisms of carbapenem resistance in Acinetobacter baumannii endemic in New York City. Clin Infect Dis. 2003; 37(2): 214-20[DOI][PubMed]
  • 17. Mahdian S, Sadeghifard N, Pakzad I, Ghanbari F, Soroush S, Azimi L, et al. Acinetobacter baumannii clonal lineages I and II harboring different carbapenem-hydrolyzing-beta-lactamase genes are widespread among hospitalized burn patients in Tehran. J Infect Public Health. 2015; 8(6): 533-42[DOI][PubMed]
  • 18. Razine R, Azzouzi A, Barkat A, Khoudri I, Hassouni F, Chefchaouni AC, et al. Prevalence of hospital-acquired infections in the university medical center of Rabat, Morocco. Int Arch Med. 2012; 5(1): 26[DOI][PubMed]
  • 19. Rubenfeld GD, Caldwell E, Peabody E, Weaver J, Martin DP, Neff M, et al. Incidence and outcomes of acute lung injury. N Engl J Med. 2005; 353(16): 1685-93[DOI][PubMed]
  • 20. Zahraei SM, Eshrati B, Masoumi Asl H, Pezeshki Z. Epidemiology of four main nosocomial infections in Iran during March 2007 - March 2008 based on the findings of a routine surveillance system. Arch Iran Med. 2012; 15(12): 764-6[PubMed]
  • 21. Talbot GH, Bradley J, Edwards JJ, Gilbert D, Scheld M, Bartlett JG, et al. Bad bugs need drugs: an update on the development pipeline from the Antimicrobial Availability Task Force of the Infectious Diseases Society of America. Clin Infect Dis. 2006; 42(5): 657-68[DOI][PubMed]
  • 22. Fournier PE, Richet H. The epidemiology and control of Acinetobacter baumannii in health care facilities. Clin Infect Dis. 2006; 42(5): 692-9[DOI][PubMed]
  • 23. Poirel L, Nordmann P. Carbapenem resistance in Acinetobacter baumannii: mechanisms and epidemiology. Clin Microbiol Infect. 2006; 12(9): 826-36[DOI][PubMed]
  • 24. Magiorakos AP, Srinivasan A, Carey RB, Carmeli Y, Falagas ME, Giske CG, et al. Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance. Clin Microbiol Infect. 2012; 18(3): 268-81[DOI][PubMed]
  • 25. Ernst EJ, Diekema DJ, BootsMiller BJ, Vaughn T, Yankey JW, Flach SD, et al. Are United States hospitals following national guidelines for the analysis and presentation of cumulative antimicrobial susceptibility data? Diagn Microbiol Infect Dis. 2004; 49(2): 141-5[DOI][PubMed]
  • 26. Jeon BC, Jeong SH, Bae IK, Kwon SB, Lee K, Young D, et al. Investigation of a nosocomial outbreak of imipenem-resistant Acinetobacter baumannii producing the OXA-23 beta-lactamase in korea. J Clin Microbiol. 2005; 43(5): 2241-5[DOI][PubMed]
  • 27. Valenzuela JK, Thomas L, Partridge SR, van der Reijden T, Dijkshoorn L, Iredell J. Horizontal gene transfer in a polyclonal outbreak of carbapenem-resistant Acinetobacter baumannii. J Clin Microbiol. 2007; 45(2): 453-60[DOI][PubMed]
  • 28. Turton JF, Gabriel SN, Valderrey C, Kaufmann ME, Pitt TL. Use of sequence-based typing and multiplex PCR to identify clonal lineages of outbreak strains of Acinetobacter baumannii. Clin Microbiol Infect. 2007; 13(8): 807-15[DOI][PubMed]
  • 29. Pradhan NP, Bhat SM, Ghadage DP. Nosocomial infections in the medical ICU: a retrospective study highlighting their prevalence, microbiological profile and impact on ICU stay and mortality. J Assoc Physicians India. 2014; 62(10): 18-21[PubMed]
  • 30. Dizbay M, Tunccan OG, Sezer BE, Hizel K. Nosocomial imipenem-resistant Acinetobacter baumannii infections: epidemiology and risk factors. Scand J Infect Dis. 2010; 42(10): 741-6[DOI][PubMed]
  • 31. Celik C, Gozel MG, Dayı F, Bakıcı MZ, Elaldı N, Gulturk E. Increasing antimicrobial resistance in nosocomial pathogens; multidrug-resistant extensively drug-resistant and pandrug-resistant Acinetobacter baumannii. J Microbiol Infect Dis. 2014; 4(1)
  • 32. Huang XZ, Chahine MA, Frye JG, Cash DM, Lesho EP, Craft DW, et al. Molecular analysis of imipenem-resistant Acinetobacter baumannii isolated from US service members wounded in Iraq, 2003-2008. Epidemiol Infect. 2012; 140(12): 2302-7[DOI][PubMed]
  • 33. Malhotra S, Sharma S, Hans C. Prevalence of hospital acquired infections in a tertiary care hospital in India. Int J Med Med Sci. 2014; 1(7): 91-4
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Cited By:

Search Relations:


  • Azad Khaledi: [PubMed] [Scholar]
  • Omid Elahifar: [PubMed] [Scholar]
  • Hossein Vazini: [PubMed] [Scholar]
  • Mohammad Yousef Alikhani: [PubMed] [Scholar]
  • Afsane Bahrami: [PubMed] [Scholar]
  • Davoud Esmaeili: [PubMed] [Scholar]
  • Kiarash Ghazvini: [PubMed] [Scholar]
  • Related Article in PubMed
  • Related Article in Google Scholar

Create Citiaion Alert via Google Reader